维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Kirschfink"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Strategies of therapeutic complement inhibition显示文摘	Mollnes T E Kirschfink M	2006	Mol Immunol2006，43，12：	1
2	Evaluation of aortic regurgitation alter transcatheter aortic valve implantation:aortic root angiography in comparison to cardiac magnetic resonance显示文摘	Frick M Meyer CG Kirschfink A	2015	EuroIntervention2015，10，11：	1
3	Study of intermittency in electron-positron annihilation into hadrons显示文摘	Braunschweig W Gerhards R Kirschfink F J	1989	Phys Lett1989，231，4：	1
4	Efficacy of ecutizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome : a case report 显示文摘	Kronbichler A Frank R Kirschfink M	2014	Medicine (Baltimore)2014，93，26：	1
5	Controlling the complement system in inflammation显示文摘	Kirschfink M	1997	Immunopharmacology1997，38，1：	1
6	Activation of complement by cold agglntinins 显示文摘	Kirschfink M Knoblanch K Roelcke D		Infusionsther Transfusionsmed0，21，6：	1
7	The Complement system in Cancer: Ambivalence between Tumour Destruction and Promotion显示文摘	Srinivas Mamidi Simon H?ne Michael Kirschfink	2015	Immunobiology2015，，：	1
8	Developing medical educators-a mixed method evaluation of a teaching education program显示文摘	Roos M Kadmon M Kirschfink M	2014	Medical Education Online2014，19，10：	1
9	Modern complement analysis显示文摘	Kirschfink M Mollnes T E	2003	Clinical and Diagnostic Laboratory Immunology2003，10，：	1
10	Comple- ment in human diseases: Lessons from complement deficiencies 显示文摘	BOTTO M KIRSCHFINK M	2009	Molecular Immunology2009，14，46：	1
11	Human C1 esterase inhibitor attenuates routine mesenteric ischemia/reperfusion induced local organ injury 显示文摘	Karpel-Massler G Fleming SD Kirschfink M	2003	Journal of Surgical Research2003，115，2：	1
12	Immune response to autologous transfusion in healthy volunteers:WB versus packed RBCs and FFP显示文摘	Frietsch T Fessler H Kirschfink M	2001	Transfusion2001，41，4：	1
13	Targeting complement in therapy显示文摘	Kirschfink M	2001	Immunol Rev2001，180，：	1
14	Specific siRNA targeting of the membrane complement regulator CD59 with herceptin immunoli- posomes sensitize breast carcinoma ceils to complement mediated cytotoxicity 显示文摘	Mamidi S Gies N Kirschfink M	2010	Clinical Immunology2010，135，：	1
15	Mechanism of complement activation during extracorporeal blood- biomaterial interaction;effects of heparin coated and uncoated surfaces 显示文摘	Mottaghy K Kirschfink M	2002	ASAIO Journal2002，48，：	1
16	C1-inhibitor:an anti-inflammatory reagent with therapeutic potential显示文摘	Kirschfink M Mollnes TE	2001	Expert Opin Pharmacother2001，2，7：	1
17	Immune response to autologous transfusion in healthy volunteers:WB versus packed RBCs and FFP显示文摘	Frietsch T Fessler H Kirschfink M	2001	Transfusion2001，41，4：	1
18	Immunoglobulin G subclass concentrations and infections in children and adolescents with severe asthma显示文摘	de Moraes Lui C Oliveira LC Diogo CL Kirschfink M Grumach AS	2002	Pediatr Allergy Immunol2002，13，3：	1
19	Brazilian Report on Primary Immunodeficiencies in Children: 166 Cases Studied Over a Follow-up Time of 15 Years显示文摘	Anete S. Grumach Alberto J. S. Duarte Raquel Bellinati-Pires Antonio C. Pastorino Cristina M. A. Jacob Constancia L. Diogo Antonio Condino-Neto Michael Kirschfink Magda M. S. Carneiro-Sampaio	1997	Journal of Clinical Immunology1997，，：	1
20	Targeting complement in therapy显示文摘	Kirschfink M	2001	Mmunological Revievs2001，180，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示